SEC-derived disclosures cited via Fintel and StockTitan indicate Point72 has recently adjusted holdings. The TeraWulf ownership page explicitly tracks new and closed positions based on regulatory filings, showing evidence of both openings and exits. Amended Schedule 13G/A filings for Palisade Bio and Avalo Therapeutics document changes in share ownership, confirming active portfolio adjustments. Additional Fintel ownership pages for large caps further corroborate ongoing position changes and link back to primary SEC filings. No contradictory evidence is presented. While these sites aggregate filings, they are based on authoritative SEC records, providing high-confidence support that Point72 has opened new positions and closed others.